CEA (Carcinoembryonic Antigen) Market Expected to Grow at More Than 6.6% CAGR From 2012 to 2022: Million Insights - Markets Insider

CEA (Carcinoembryonic Antigen) Market Expected to Grow at More Than 6.6% CAGR From 2012 to 2022: Million Insights Markets Insider This segment include key application, namely colorectal, ovarian, pancreatic, breast, thyroid and other cancer applications. In 2016, colorectal cancer dominated the market in terms of revenue share. Rising incidence of colorectal cancer and increase ... and more »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vkPXhr
via IFTTT